MALAYSIAN BIO-XCELL TAKES THE STAGE AT BIO
DEPUTY PRIME MINISTER OF MALAYSIA WILL HAVE THE HONOUR OF OFFICIATING THE BIO INTERNATIONAL EXHIBITION 2011
Washington
DC, Monday, 27 June 2011-
Heading the Malaysian delegation is the Right Honourable Tan Sri Muhyiddin Yassin, Deputy Prime Minister of Malaysia who will be given the honour to officiate the BIO international exhibition in the ribbon cutting ceremony, alongside Governor O’Malley and James Greenwood, President and CEO of BIO on 28 June 2011.
The global event for biotechnology provides a strong pipeline of investment flows into Malaysia.
“The annual Bio international Convention and Exhibition has been a platform for lead generation, industry benchmarking, and global collaboration and partnerships,” said Dr Wan Abdul Rahaman Wan Yaacob, Chief Operating Officer of BiotechCorp.
“We launched Bio-XCell in Bio Chicago in last year, and since then we have secured three global industry leaders in our park and ecosystem– Biocon of India, a global player in biopharma and Metabolic Explorer of France and Glycos Biotechnologies of the US in industrial biotechnology with investments worth more than USD200 million.
A dedicated Biotechnology hub, catering to the bioprocessing and biomanufacturing needs of global and regional players, Bio-XCell is the strategic tool to carry the commercialization strategy of BiotechCorp, in line with phase 2 of the National Biotechnology Policy (NBP) – in bringing innovations from lab to market.
The Deputy Prime Minister is also scheduled to officiate the Bio-XCell exhibition booth.
“Tomorrow, we will exchange a couple of agreements before The Right Honourable Deputy Prime Minister which will mark yet another significant step towards enhancing the infrastructure of the ecosystem and also its tenant mix,” said Raja Ridzwa Raja Abdul Aziz, CEO of Bio-XCell.
BiotechCorp will also see a couple of MOC/MOU exchanged between Malaysian biotech companies and global counterparts from Russia and Norway, enhancing Malaysia’s edge in the space of industrial biotechnology.
Several significant milestones and announcements will be made by BiotechCorp and Bio-XCell throughout BIO DC 2011.
“It will also be a big step for our annual BioMalaysia this year as for the first time we will be co-hosting the 2011 BioMalaysia with the 2011 Bio Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This is a big step for BioMalaysia and we are taking the event one step further. We will be announcing this at a Curtain Raiser event during Bio DC.
Dato’ Iskandar said “For the very first time ever, the 2011 Pacific Rim Summit in Industrial Biotechnology and bioenergy will be held outside the US. This collaboration will help place Malaysia on the global map of industrial biotechnology and highlight Malaysia’s competitive advantage in industrial bio-processing and bio-manufacturing”.
“We are happy to add value to the BIO event this year with a number of speaking engagements within the conference”, he added.
The Deputy Minister of Ministry of Science and Innovation, YBhg Dato’ Haji Fadillah Yusoff, will be speaking at the Leadership Summit Session and Professor Dr. Rofina Yasmin, Under Secretary Biotech will be speaking during the Breakout Session, entitled Going Global Overnight. Meanwhile, the CEO of BiotechCorp, Dato’ Iskandar Mizal Mahmood will be participating as panelist at the Scientific American Super Session on Worldview 2011.
Overall, the biotechnology industry has marked impressive and encouraging achievements. Some important highlights in Malaysian biotechnology industry include:
- The Malaysian biotechnology industry is now in the “Comercialisation’ phase as indicated in the National Biotechnology Policy.
- In five short years, the industry has managed to attract RM5.4 billion worth of investments, acquired a total of RM13.5 billion in revenue and provided 54,776 jobs opportunities. With the 2.2% contribution towards the GDP.
- A total of 188 BioNexus companies was nurtured and grown with total approved investment of RM1.96 billion. Five companies are now listed on international and local stock exchanges with market capitalization totaling close to RM1 billion.
- The targets for Phase Two are higher with a 150% increase in investment (RM9 billion) and revenue (RM50) and a 100% increase in employment opportunities (80,000). The industry is expected to contribute 4.5 percent to GDP.
BiotechCorp will continue to accelerate commercialization in biotechnology to transform Malaysia into a knowledge-based economy and an industrialized nation by year 2020.
Malaysian Bio-XCell Sdn Bhd (Bio-XCell), a subsidiary of Malaysian Biotechnology Corporation (BiotechCorp), will showcase Malaysia’s biotechnology ecosystem and the country’s strength as a regional biotech hub at the Bio International Convention 2011 (BIO DC) from 27 – 30 June, 2011 in Walter E. Washington Convention Centre.
About BiotechCorp
BiotechCorp is the lead development agency for the biotech industry in Malaysia and acts as a central contact point providing support, facilitation and advisory services for biotech and life sciences companies in Malaysia.
Since its establishment in 2005, BiotechCorp has played a key role in building the biotech industry in Malaysia. To date, BiotechCorp has facilitated the development of 188BioNexus-status companies in Malaysia with total approved investment of RM 1.96 billion.
BioNexus-status companies are international and Malaysian biotech companies that qualify for fiscal incentives, grants and guarantees administered by BiotechCorp. For further details, visit
www.biotechcorp.com.my
.
For media inquiries, kindly contact:
HASLINA HAMIDAN
Corporate Affairs Manager
Tel/Fax: +60321165458 / 202 746 2091
Email : haslina.hamidan@biotechcorp.com.my
INTERNATIONAL CONVENTION 2011, WASHINGTON
DC
